Top Penny Stock Signal: ARDX
Report Date: 06-25-2022
Symbol: ARDX - Ardelyx, Inc.
Sector:
Industry:
Top Penny Stock Signal: ARDX
Ardelyx, Inc. (ARDX)
34175 Ardenwood Blvd
Fremont, CALIFORNIA 94555
Phone: 15107457047
Website: http://www.ardelyx.com
CEO: Mr. Michael Raab
NASDAQ, Nasdaq Global Market
Ardelyx, Inc., a biopharmaceutical company, develops and sells medicines for the treatment of cardiorenal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase 3 clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase 3 clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.